Home Healthcare Biotechnology Genotyping Market

Genotyping Market Size, Share & Trends Analysis Report By Technology (Direct PCR, Others), By Applications (Alzheimer's Disease, Parkinson’s Disease, Multiple Sclerosis, Autism Spectrum Disorders, Others), By End-User (Pharmaceutical and Biopharmaceutical Companies, Diagnostics and Research Laboratories, Academic Institutes, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Dhanashri B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Genotyping Market, By Technology 2022-2034 (USD MILLION/ Units)
    1. Direct PCR
    2. Others
  2. Genotyping Market, By Applications 2022-2034 (USD MILLION/ Units)
    1. Alzheimer's Disease
    2. Parkinson’s Disease
    3. Multiple Sclerosis
    4. Autism Spectrum Disorders
    5. Others
  3. Genotyping Market, By End-User 2022-2034 (USD MILLION/ Units)
    1. Pharmaceutical and Biopharmaceutical Companies
    2. Diagnostics and Research Laboratories
    3. Academic Institutes
    4. Others
  4. Regional Genotyping Market
    1. North America
      1. North America Genotyping Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Direct PCR
        2. Others
      2. North America Genotyping Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Alzheimer's Disease
        2. Parkinson’s Disease
        3. Multiple Sclerosis
        4. Autism Spectrum Disorders
        5. Others
      3. North America Genotyping Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biopharmaceutical Companies
        2. Diagnostics and Research Laboratories
        3. Academic Institutes
        4. Others
      4. U.S.
        1. Direct PCR
        2. Others
        3. Alzheimer's Disease
        4. Parkinson’s Disease
        5. Multiple Sclerosis
        6. Autism Spectrum Disorders
        7. Others
        8. Pharmaceutical and Biopharmaceutical Companies
        9. Diagnostics and Research Laboratories
        10. Academic Institutes
        11. Others
      5. Canada
        1. Direct PCR
        2. Others
        3. Alzheimer's Disease
        4. Parkinson’s Disease
        5. Multiple Sclerosis
        6. Autism Spectrum Disorders
        7. Others
        8. Pharmaceutical and Biopharmaceutical Companies
        9. Diagnostics and Research Laboratories
        10. Academic Institutes
        11. Others
    2. Europe
      1. Europe Genotyping Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Direct PCR
        2. Others
      2. Europe Genotyping Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Alzheimer's Disease
        2. Parkinson’s Disease
        3. Multiple Sclerosis
        4. Autism Spectrum Disorders
        5. Others
      3. Europe Genotyping Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biopharmaceutical Companies
        2. Diagnostics and Research Laboratories
        3. Academic Institutes
        4. Others
      4. U.K.
        1. Direct PCR
        2. Others
        3. Alzheimer's Disease
        4. Parkinson’s Disease
        5. Multiple Sclerosis
        6. Autism Spectrum Disorders
        7. Others
        8. Pharmaceutical and Biopharmaceutical Companies
        9. Diagnostics and Research Laboratories
        10. Academic Institutes
        11. Others
      5. Germany
        1. Direct PCR
        2. Others
        3. Alzheimer's Disease
        4. Parkinson’s Disease
        5. Multiple Sclerosis
        6. Autism Spectrum Disorders
        7. Others
        8. Pharmaceutical and Biopharmaceutical Companies
        9. Diagnostics and Research Laboratories
        10. Academic Institutes
        11. Others
      6. France
        1. Direct PCR
        2. Others
        3. Alzheimer's Disease
        4. Parkinson’s Disease
        5. Multiple Sclerosis
        6. Autism Spectrum Disorders
        7. Others
        8. Pharmaceutical and Biopharmaceutical Companies
        9. Diagnostics and Research Laboratories
        10. Academic Institutes
        11. Others
      7. Spain
        1. Direct PCR
        2. Others
        3. Alzheimer's Disease
        4. Parkinson’s Disease
        5. Multiple Sclerosis
        6. Autism Spectrum Disorders
        7. Others
        8. Pharmaceutical and Biopharmaceutical Companies
        9. Diagnostics and Research Laboratories
        10. Academic Institutes
        11. Others
      8. Italy
        1. Direct PCR
        2. Others
        3. Alzheimer's Disease
        4. Parkinson’s Disease
        5. Multiple Sclerosis
        6. Autism Spectrum Disorders
        7. Others
        8. Pharmaceutical and Biopharmaceutical Companies
        9. Diagnostics and Research Laboratories
        10. Academic Institutes
        11. Others
      9. Russia
        1. Direct PCR
        2. Others
        3. Alzheimer's Disease
        4. Parkinson’s Disease
        5. Multiple Sclerosis
        6. Autism Spectrum Disorders
        7. Others
        8. Pharmaceutical and Biopharmaceutical Companies
        9. Diagnostics and Research Laboratories
        10. Academic Institutes
        11. Others
      10. Nordic
        1. Direct PCR
        2. Others
        3. Alzheimer's Disease
        4. Parkinson’s Disease
        5. Multiple Sclerosis
        6. Autism Spectrum Disorders
        7. Others
        8. Pharmaceutical and Biopharmaceutical Companies
        9. Diagnostics and Research Laboratories
        10. Academic Institutes
        11. Others
      11. Benelux
        1. Direct PCR
        2. Others
        3. Alzheimer's Disease
        4. Parkinson’s Disease
        5. Multiple Sclerosis
        6. Autism Spectrum Disorders
        7. Others
        8. Pharmaceutical and Biopharmaceutical Companies
        9. Diagnostics and Research Laboratories
        10. Academic Institutes
        11. Others
      12. Rest of Europe
        1. Direct PCR
        2. Others
        3. Alzheimer's Disease
        4. Parkinson’s Disease
        5. Multiple Sclerosis
        6. Autism Spectrum Disorders
        7. Others
        8. Pharmaceutical and Biopharmaceutical Companies
        9. Diagnostics and Research Laboratories
        10. Academic Institutes
        11. Others
    3. APAC
      1. APAC Genotyping Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Direct PCR
        2. Others
      2. APAC Genotyping Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Alzheimer's Disease
        2. Parkinson’s Disease
        3. Multiple Sclerosis
        4. Autism Spectrum Disorders
        5. Others
      3. APAC Genotyping Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biopharmaceutical Companies
        2. Diagnostics and Research Laboratories
        3. Academic Institutes
        4. Others
      4. China
        1. Direct PCR
        2. Others
        3. Alzheimer's Disease
        4. Parkinson’s Disease
        5. Multiple Sclerosis
        6. Autism Spectrum Disorders
        7. Others
        8. Pharmaceutical and Biopharmaceutical Companies
        9. Diagnostics and Research Laboratories
        10. Academic Institutes
        11. Others
      5. Korea
        1. Direct PCR
        2. Others
        3. Alzheimer's Disease
        4. Parkinson’s Disease
        5. Multiple Sclerosis
        6. Autism Spectrum Disorders
        7. Others
        8. Pharmaceutical and Biopharmaceutical Companies
        9. Diagnostics and Research Laboratories
        10. Academic Institutes
        11. Others
      6. Japan
        1. Direct PCR
        2. Others
        3. Alzheimer's Disease
        4. Parkinson’s Disease
        5. Multiple Sclerosis
        6. Autism Spectrum Disorders
        7. Others
        8. Pharmaceutical and Biopharmaceutical Companies
        9. Diagnostics and Research Laboratories
        10. Academic Institutes
        11. Others
      7. India
        1. Direct PCR
        2. Others
        3. Alzheimer's Disease
        4. Parkinson’s Disease
        5. Multiple Sclerosis
        6. Autism Spectrum Disorders
        7. Others
        8. Pharmaceutical and Biopharmaceutical Companies
        9. Diagnostics and Research Laboratories
        10. Academic Institutes
        11. Others
      8. Australia
        1. Direct PCR
        2. Others
        3. Alzheimer's Disease
        4. Parkinson’s Disease
        5. Multiple Sclerosis
        6. Autism Spectrum Disorders
        7. Others
        8. Pharmaceutical and Biopharmaceutical Companies
        9. Diagnostics and Research Laboratories
        10. Academic Institutes
        11. Others
      9. Taiwan
        1. Direct PCR
        2. Others
        3. Alzheimer's Disease
        4. Parkinson’s Disease
        5. Multiple Sclerosis
        6. Autism Spectrum Disorders
        7. Others
        8. Pharmaceutical and Biopharmaceutical Companies
        9. Diagnostics and Research Laboratories
        10. Academic Institutes
        11. Others
      10. South East Asia
        1. Direct PCR
        2. Others
        3. Alzheimer's Disease
        4. Parkinson’s Disease
        5. Multiple Sclerosis
        6. Autism Spectrum Disorders
        7. Others
        8. Pharmaceutical and Biopharmaceutical Companies
        9. Diagnostics and Research Laboratories
        10. Academic Institutes
        11. Others
      11. Rest of Asia-Pacific
        1. Direct PCR
        2. Others
        3. Alzheimer's Disease
        4. Parkinson’s Disease
        5. Multiple Sclerosis
        6. Autism Spectrum Disorders
        7. Others
        8. Pharmaceutical and Biopharmaceutical Companies
        9. Diagnostics and Research Laboratories
        10. Academic Institutes
        11. Others
    4. Middle East and Africa
      1. Middle East and Africa Genotyping Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Direct PCR
        2. Others
      2. Middle East and Africa Genotyping Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Alzheimer's Disease
        2. Parkinson’s Disease
        3. Multiple Sclerosis
        4. Autism Spectrum Disorders
        5. Others
      3. Middle East and Africa Genotyping Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biopharmaceutical Companies
        2. Diagnostics and Research Laboratories
        3. Academic Institutes
        4. Others
      4. UAE
        1. Direct PCR
        2. Others
        3. Alzheimer's Disease
        4. Parkinson’s Disease
        5. Multiple Sclerosis
        6. Autism Spectrum Disorders
        7. Others
        8. Pharmaceutical and Biopharmaceutical Companies
        9. Diagnostics and Research Laboratories
        10. Academic Institutes
        11. Others
      5. Turkey
        1. Direct PCR
        2. Others
        3. Alzheimer's Disease
        4. Parkinson’s Disease
        5. Multiple Sclerosis
        6. Autism Spectrum Disorders
        7. Others
        8. Pharmaceutical and Biopharmaceutical Companies
        9. Diagnostics and Research Laboratories
        10. Academic Institutes
        11. Others
      6. Saudi Arabia
        1. Direct PCR
        2. Others
        3. Alzheimer's Disease
        4. Parkinson’s Disease
        5. Multiple Sclerosis
        6. Autism Spectrum Disorders
        7. Others
        8. Pharmaceutical and Biopharmaceutical Companies
        9. Diagnostics and Research Laboratories
        10. Academic Institutes
        11. Others
      7. South Africa
        1. Direct PCR
        2. Others
        3. Alzheimer's Disease
        4. Parkinson’s Disease
        5. Multiple Sclerosis
        6. Autism Spectrum Disorders
        7. Others
        8. Pharmaceutical and Biopharmaceutical Companies
        9. Diagnostics and Research Laboratories
        10. Academic Institutes
        11. Others
      8. Egypt
        1. Direct PCR
        2. Others
        3. Alzheimer's Disease
        4. Parkinson’s Disease
        5. Multiple Sclerosis
        6. Autism Spectrum Disorders
        7. Others
        8. Pharmaceutical and Biopharmaceutical Companies
        9. Diagnostics and Research Laboratories
        10. Academic Institutes
        11. Others
      9. Nigeria
        1. Direct PCR
        2. Others
        3. Alzheimer's Disease
        4. Parkinson’s Disease
        5. Multiple Sclerosis
        6. Autism Spectrum Disorders
        7. Others
        8. Pharmaceutical and Biopharmaceutical Companies
        9. Diagnostics and Research Laboratories
        10. Academic Institutes
        11. Others
      10. Rest of MEA
        1. Direct PCR
        2. Others
        3. Alzheimer's Disease
        4. Parkinson’s Disease
        5. Multiple Sclerosis
        6. Autism Spectrum Disorders
        7. Others
        8. Pharmaceutical and Biopharmaceutical Companies
        9. Diagnostics and Research Laboratories
        10. Academic Institutes
        11. Others
    5. LATAM
      1. LATAM Genotyping Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Direct PCR
        2. Others
      2. LATAM Genotyping Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Alzheimer's Disease
        2. Parkinson’s Disease
        3. Multiple Sclerosis
        4. Autism Spectrum Disorders
        5. Others
      3. LATAM Genotyping Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biopharmaceutical Companies
        2. Diagnostics and Research Laboratories
        3. Academic Institutes
        4. Others
      4. Brazil
        1. Direct PCR
        2. Others
        3. Alzheimer's Disease
        4. Parkinson’s Disease
        5. Multiple Sclerosis
        6. Autism Spectrum Disorders
        7. Others
        8. Pharmaceutical and Biopharmaceutical Companies
        9. Diagnostics and Research Laboratories
        10. Academic Institutes
        11. Others
      5. Mexico
        1. Direct PCR
        2. Others
        3. Alzheimer's Disease
        4. Parkinson’s Disease
        5. Multiple Sclerosis
        6. Autism Spectrum Disorders
        7. Others
        8. Pharmaceutical and Biopharmaceutical Companies
        9. Diagnostics and Research Laboratories
        10. Academic Institutes
        11. Others
      6. Argentina
        1. Direct PCR
        2. Others
        3. Alzheimer's Disease
        4. Parkinson’s Disease
        5. Multiple Sclerosis
        6. Autism Spectrum Disorders
        7. Others
        8. Pharmaceutical and Biopharmaceutical Companies
        9. Diagnostics and Research Laboratories
        10. Academic Institutes
        11. Others
      7. Chile
        1. Direct PCR
        2. Others
        3. Alzheimer's Disease
        4. Parkinson’s Disease
        5. Multiple Sclerosis
        6. Autism Spectrum Disorders
        7. Others
        8. Pharmaceutical and Biopharmaceutical Companies
        9. Diagnostics and Research Laboratories
        10. Academic Institutes
        11. Others
      8. Colombia
        1. Direct PCR
        2. Others
        3. Alzheimer's Disease
        4. Parkinson’s Disease
        5. Multiple Sclerosis
        6. Autism Spectrum Disorders
        7. Others
        8. Pharmaceutical and Biopharmaceutical Companies
        9. Diagnostics and Research Laboratories
        10. Academic Institutes
        11. Others
      9. Rest of LATAM
        1. Direct PCR
        2. Others
        3. Alzheimer's Disease
        4. Parkinson’s Disease
        5. Multiple Sclerosis
        6. Autism Spectrum Disorders
        7. Others
        8. Pharmaceutical and Biopharmaceutical Companies
        9. Diagnostics and Research Laboratories
        10. Academic Institutes
        11. Others
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.